Abstracts tagged "Cancer and myositis"

Abstract Number: 984 • 2016 ACR/ARHP Annual Meeting
Clinical Characteristics of Inflammatory Myopathies Associated with Cancer: A Report from the Remicam Registry
Isabel de la Cámara Fernández¹, Patricia Carreira², Beatriz E. Joven³, Francisco Javier López Longo⁴, Tatiana Cobo-Ibáñez⁵, Leticia Lojo⁶, Carmen Larena⁷, Carmen Barbadillo⁸, Julia Martínez-Barrio⁹, Juan Carlos Lopez-Robledillo¹⁰, Paloma Garcia De La Peña¹¹, Eva Tomero¹², Irene Llorente¹³, Henry Moruno Cruz¹⁴, Ana Pérez Gómez¹⁴, Laura Nuño¹⁵, Raquel Almodóvar González¹⁶, VALENTINA MALDONADO¹⁷, Lucía Ruiz Gutiérrez¹⁴ and MARIA JESUS GARCIA DE YEBENES Y PROUS¹⁸, ¹RHEUMATOLOGY, RHEUMATOLOGY DEPARTMENT. HOSPITAL 12 DE OCTUBRE, MADRID, Spain, ²Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ³Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ⁴Rheumatology, Hospital Gregorio Marañón, Madrid, Spain, ⁵Hospital Universitario Reina Sofía, Universidad Europea de Madrid, Madrid, Spain, ⁶Rheumatology, Hospital Universitario La Paz, Spain, Spain, ⁷Hospital Gregorio Marañón, Madrid, Spain, ⁸Hospital Universitario Puerta de Hierro, Madrid, Spain, ⁹Servicio de Reumatologia, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ¹⁰Hospital Niño Jesus, Madrid, Spain, ¹¹Rheumatology, Hospital Madrid Norte Sanchinarro, Madrid, Spain, ¹²Hospital La Princesa. Madrid., Madrid, Spain, ¹³Rheumatology, H.U. La Princesa, Madrid, Spain, ¹⁴University Hospital Príncipe de Asturias, Immune System Diseases, Rheumatology department, Alcalá de Henares, Madrid, Spain, ¹⁵Servicio de Reumatologia, Hospital Universitario La Paz, Madrid, Spain, ¹⁶Rheumatology Unit, Hospital Universitario Fundación Alcorcón, Madrid, Spain, ¹⁷RHEUMATOLOGY, RHEUMATOLOGY DEPARTMENT. HOSPITAL RAMON Y CAJAL, MADRID, Spain, ¹⁸INSTITUTO DE SALUD MUSCULOESQUELÉTICA, MADRID, Spain
Background/Purpose: To describe the clinical presentation and associations of patients with IM associated with cancer in a large group of inflamatory myopathy (IM) from the…
Abstract Number: 1188 • 2016 ACR/ARHP Annual Meeting
Major Comorbidities of Idiopathic Inflammatory Myositis: A Population-Based Study Using 10 Years of Follow up from the National Health Insurance in Korea
Jeong Seok Lee¹, Min Jung Kim², Hee Young Lee³, So Yeon Ahn⁴, Yeong Wook Song⁵, Eun Bong Lee⁶, Eun Young Lee⁷, Yun Jong Lee⁸ and Eun Ha Kang⁹, ¹Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, ²Division of Rheumatology, Departmenf of Internal Medicine, Seoul National University Hospital, Seoul, Korea, The Republic of, ³Center for Preventive Medicine and Public health, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of, ⁴Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of, ⁵Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, Republic of Korea, Seoul, Korea, The Republic of, ⁶Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea, Seoul, Korea, The Republic of, ⁷Division of Rheumatology, Department of Internal Medicine, Seoul National University, Seoul, South Korea, ⁸Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea, ⁹Division of Rheumatology, Department of Internal Medicine, Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, The Republic of
Major comorbidities of idiopathic inflammatory myositis: A population-based study using 10 years of follow up from the national health insurance in KoreaJeong Seok Lee1, Min…
Abstract Number: 2215 • 2014 ACR/ARHP Annual Meeting
Clinical Characteristics and Prognosis of Malignancies Associated with Active Myositis
Sang Jin Lee¹, Eun Ha Kang², Yun Jong Lee², Eun Young Lee³ and Yeong Wook Song⁴, ¹Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea, ²Division of Rheumatology, Department of Internal Medicine,Seoul National University Bundang Hospital, Seongnam, South Korea, ³Division of Rheumatology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea, ⁴Department of Molecular Medicine and Biopharmaceutical Sciences, BK 21 plus Graduate School of Convergence Science and Technology, and College of Medicine, Seoul National University, Seoul, South Korea
Background/Purpose: To examine the clinical features and prognosis of cancers associated with active myositis and to compare them with cancers found in patients with myositis…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].